Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan seeks deeper Asia-Pacific ties, higher defense spending: Lai
08/28/2025 12:12 PM - Politics
Taiwan silent on reports foreign minister joined Philippines business trip
08/28/2025 11:36 AM - Society
Taiwan headline news
08/28/2025 10:40 AM - Business
Taiwan shares open lower
08/28/2025 09:12 AM - Society
Magnitude 6 earthquake rocks northeastern Taiwan
08/27/2025 09:38 PM